JPWO2020065613A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020065613A5
JPWO2020065613A5 JP2021517202A JP2021517202A JPWO2020065613A5 JP WO2020065613 A5 JPWO2020065613 A5 JP WO2020065613A5 JP 2021517202 A JP2021517202 A JP 2021517202A JP 2021517202 A JP2021517202 A JP 2021517202A JP WO2020065613 A5 JPWO2020065613 A5 JP WO2020065613A5
Authority
JP
Japan
Prior art keywords
pyridin
pyrazolo
methanone
dimethyl
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021517202A
Other languages
English (en)
Japanese (ja)
Other versions
JP7482116B2 (ja
JP2022502424A (ja
JP2022502424A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/058240 external-priority patent/WO2020065613A1/en
Publication of JP2022502424A publication Critical patent/JP2022502424A/ja
Publication of JPWO2020065613A5 publication Critical patent/JPWO2020065613A5/ja
Publication of JP2022502424A5 publication Critical patent/JP2022502424A5/ja
Priority to JP2024043368A priority Critical patent/JP2024096702A/ja
Application granted granted Critical
Publication of JP7482116B2 publication Critical patent/JP7482116B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021517202A 2018-09-28 2019-09-27 モノアシルグリセロールリパーゼ調節因子 Active JP7482116B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024043368A JP2024096702A (ja) 2018-09-28 2024-03-19 モノアシルグリセロールリパーゼ調節因子

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862738600P 2018-09-28 2018-09-28
US62/738,600 2018-09-28
PCT/IB2019/058240 WO2020065613A1 (en) 2018-09-28 2019-09-27 Monoacylglycerol lipase modulators

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024043368A Division JP2024096702A (ja) 2018-09-28 2024-03-19 モノアシルグリセロールリパーゼ調節因子

Publications (4)

Publication Number Publication Date
JP2022502424A JP2022502424A (ja) 2022-01-11
JPWO2020065613A5 true JPWO2020065613A5 (https=) 2022-10-05
JP2022502424A5 JP2022502424A5 (https=) 2022-10-05
JP7482116B2 JP7482116B2 (ja) 2024-05-13

Family

ID=68109428

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021517202A Active JP7482116B2 (ja) 2018-09-28 2019-09-27 モノアシルグリセロールリパーゼ調節因子
JP2024043368A Pending JP2024096702A (ja) 2018-09-28 2024-03-19 モノアシルグリセロールリパーゼ調節因子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024043368A Pending JP2024096702A (ja) 2018-09-28 2024-03-19 モノアシルグリセロールリパーゼ調節因子

Country Status (26)

Country Link
US (3) US20200102303A1 (https=)
EP (1) EP3856178B1 (https=)
JP (2) JP7482116B2 (https=)
KR (1) KR102911066B1 (https=)
CN (1) CN113164459B (https=)
AU (2) AU2019350624B2 (https=)
BR (1) BR112021005896A2 (https=)
CA (1) CA3111380A1 (https=)
CL (1) CL2021000757A1 (https=)
CO (1) CO2021003944A2 (https=)
CR (1) CR20210153A (https=)
DO (1) DOP2021000051A (https=)
EA (1) EA202190886A1 (https=)
EC (1) ECSP21021381A (https=)
IL (1) IL281812A (https=)
JO (1) JOP20210058A1 (https=)
MA (1) MA53721A (https=)
MX (1) MX2021003737A (https=)
MY (1) MY205440A (https=)
NI (1) NI202100023A (https=)
PE (1) PE20211773A1 (https=)
PH (1) PH12021550659A1 (https=)
SA (2) SA522441561B1 (https=)
SG (1) SG11202102281VA (https=)
TW (1) TWI863931B (https=)
WO (1) WO2020065613A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI644671B (zh) 2013-03-14 2018-12-21 比利時商健生藥品公司 P2x7調節劑
EP3856178B1 (en) 2018-09-28 2026-03-11 Janssen Pharmaceutica NV Monoacylglycerol lipase modulators
WO2020065614A1 (en) 2018-09-28 2020-04-02 Janssen Pharmaceutica Nv Monoacylglycerol lipase modulators
US20220315602A1 (en) * 2019-06-04 2022-10-06 Hager Biosciences, Llc Pyrazole and imidazole derivatives, compositions and methods as orexin antagonists
MX2022003819A (es) * 2019-09-30 2022-05-11 Janssen Pharmaceutica Nv Ligandos de pet de mgl radiomarcados.
BR112022019077A2 (pt) * 2020-03-26 2022-12-27 Janssen Pharmaceutica Nv Moduladores da monoacilglicerol lipase
WO2022150962A1 (en) * 2021-01-12 2022-07-21 Westlake Pharmaceutical (Hangzhou) Co., Ltd. Protease inhibitors, preparation, and uses thereof
US20240270743A1 (en) * 2021-08-11 2024-08-15 Landos Biopharma, Inc. Tetrahydropyrazolopyridine-analog ligands of nlrx1 and uses thereof
AR127955A1 (es) 2021-12-16 2024-03-13 Hoffmann La Roche Nuevos compuestos heterocíclicos
CA3242372A1 (en) 2021-12-29 2023-07-06 Psy Therapeutics, Inc. Inhibiting monoacylglycerol lipase (magl)
CN115872995B (zh) * 2022-12-27 2024-10-01 上海凌凯科技股份有限公司 一种吡唑并吡啶化合物及一种羧酸衍生物的制备方法
CN116606298A (zh) * 2023-05-26 2023-08-18 康化(上海)新药研发有限公司 2,3-二氢-[1,4]二噁烷并[2,3-b]吡啶-8-羧酸的合成方法

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816463A (en) 1986-04-01 1989-03-28 Warner-Lambert Company Substituted diimidazo [1,5-a: 4',5'-d]pyridines having antihypertensive activity
US4812462A (en) 1986-04-01 1989-03-14 Warner-Lambert Company 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity
WO1992005784A1 (en) 1990-10-02 1992-04-16 Warner-Lambert Company 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine derivatives and analogues as angiotensin ii receptor antagonists
JP2005537290A (ja) 2002-07-25 2005-12-08 ファルマシア・イタリア・エス・ピー・エー キナーゼ阻害剤として活性なビシクロピラゾール類、その製造方法、およびそれを含有する薬学的組成物
CA2493625A1 (en) 2002-07-25 2004-02-19 Pharmacia Italia S.P.A. Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
US7145012B2 (en) 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
FR2857363B1 (fr) 2003-07-10 2007-09-07 Aventis Pharma Sa 4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees compositions les contenant et utilisation
AR045037A1 (es) * 2003-07-10 2005-10-12 Aventis Pharma Sa Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion.
ATE546452T1 (de) 2003-09-23 2012-03-15 Vertex Pharma Pyrazolopyrrolderivate als proteinkinaseinhibitoren
AU2005277283A1 (en) 2004-08-23 2006-03-02 Merck Sharp & Dohme Corp. Fused triazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
US20080146612A1 (en) 2005-01-27 2008-06-19 Astrazeneca Ab Novel Biaromatic Compounds, Inhibitors of the P2X7-Receptor
US7297700B2 (en) 2005-03-24 2007-11-20 Renovis, Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
WO2006110516A1 (en) 2005-04-11 2006-10-19 Abbott Laboratories Acylhydrazide p2x7 antagonists and uses thereof
JP2009531390A (ja) 2006-03-31 2009-09-03 ノバルティス アクチエンゲゼルシャフト 有機化合物
US7943617B2 (en) 2006-11-27 2011-05-17 Bristol-Myers Squibb Company Heterobicyclic compounds useful as kinase inhibitors
FR2915197B1 (fr) 2007-04-18 2009-06-12 Sanofi Aventis Sa Derives de triazolopyridine-carboxamides, leur preparation et leur application therapeutique.
US8349858B2 (en) 2007-06-21 2013-01-08 Merck Sharp & Dohme Polycyclic guanine derivatives and use thereof
WO2009023623A1 (en) 2007-08-10 2009-02-19 H, Lundbeck A/S Heteroaryl amide analogues
FR2921342B1 (fr) 2007-09-20 2010-03-12 Airbus France Carenage aerodynamique arriere inferieur pour dispositif d'accrochage d'un moteur d'aeronef
EP2090576A1 (en) 2008-02-01 2009-08-19 Merz Pharma GmbH & Co.KGaA 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators
CA2722035C (en) 2008-04-22 2016-10-11 Janssen Pharmaceutica Nv Quinoline or isoquinoline substituted p2x7 antagonists
EP2370437B1 (en) 2008-11-25 2013-09-04 Nerviano Medical Sciences S.r.l. Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
WO2010066629A2 (en) 2008-12-09 2010-06-17 F. Hoffmann-La Roche Ag Novel azaindoles
WO2010124122A1 (en) 2009-04-22 2010-10-28 Janssen Pharmaceutica Nv Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
US8455476B2 (en) 2009-04-22 2013-06-04 Janssen Pharmaceutica, Nv Azetidinyl diamides as monoacylglycerol lipase inhibitors
ES2590987T3 (es) 2009-04-29 2016-11-24 Glaxo Group Limited Derivados de 5,6,7,8-tetrahidro[1,2,4]triazolo[4,3-a]pirazina como moduladores de P2X7
GB0907515D0 (en) 2009-04-30 2009-06-10 Glaxo Group Ltd Compounds
US8871760B2 (en) 2009-09-21 2014-10-28 Roche Palo Alto Llc [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators
WO2011050202A1 (en) 2009-10-23 2011-04-28 Janssen Pharmaceutica Nv Fused heterocyclic compounds as orexin receptor modulators
WO2011103715A1 (en) 2010-02-25 2011-09-01 Merck Sharp & Dohme Corp. Task channel antagonists
EP2552920B1 (en) 2010-04-02 2017-03-15 Ogeda Sa Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders
EP2558661A4 (en) 2010-04-16 2014-10-29 Fernandez Rodrigo Graf FOLDABLE STRUCTURES FOR CONSTRUCTION
US9242981B2 (en) 2010-09-16 2016-01-26 Merck Sharp & Dohme Corp. Fused pyrazole derivatives as novel ERK inhibitors
US20130196986A1 (en) 2010-09-21 2013-08-01 Marc Labroli Triazolopyrazinones as p2x7 receptor antagonists
JP2013537920A (ja) * 2010-09-27 2013-10-07 ヤンセン ファーマシューティカ エヌ.ベー. モノアシルグリセロールリパーゼ阻害剤としてのオキソピペラジン−アゼチジンアミド及びオキソジアゼピン−アゼチジンアミド
WO2012054716A1 (en) 2010-10-22 2012-04-26 Janssen Pharmaceutica Nv. Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors
JP2013540160A (ja) * 2010-10-22 2013-10-31 ヤンセン ファーマシューティカ エヌ.ベー. モノアシルグリセロールリパーゼ阻害剤としてのアミノ−ピロリジン−アゼチジンジアミド
US9586962B2 (en) 2011-04-20 2017-03-07 Janssen Pharmaceutica Nv Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators
WO2013050424A1 (en) 2011-10-03 2013-04-11 Euroscreen S.A. NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF
EP2766345B1 (en) * 2011-10-14 2016-03-16 Bristol-Myers Squibb Company Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
US9273947B2 (en) 2012-02-07 2016-03-01 Lg Innotek Co., Ltd. Sensing magnet apparatus for motor
JP5205547B1 (ja) 2012-04-20 2013-06-05 株式会社ノイズ研究所 放射信号可視化装置
US9056874B2 (en) 2012-05-04 2015-06-16 Novartis Ag Complement pathway modulators and uses thereof
CN104718188B (zh) 2012-05-22 2018-08-21 基因泰克公司 N-取代的苯甲酰胺类及其在治疗疼痛中的用途
US8859774B2 (en) 2012-05-25 2014-10-14 Corcept Therapeutics, Inc. Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
JO3459B1 (ar) 2012-09-09 2020-07-05 H Lundbeck As تركيبات صيدلانية لعلاج مرض الزهايمر
MX2015004721A (es) 2012-10-15 2016-01-25 Epizyme Inc Compuestos de benceno sustituidos.
MY189505A (en) 2012-10-16 2022-02-16 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of roryt
CN104918945B (zh) 2012-11-01 2018-01-05 因赛特公司 作为jak抑制剂的三环稠合噻吩衍生物
US9796729B2 (en) 2012-11-23 2017-10-24 Glaxosmithkline Llc Compounds as diacylglycerol acyltransferase inhibitors
WO2014100818A1 (en) 2012-12-21 2014-06-26 Quanticel Pharmaceuticals, Inc. Histone demethylase inhibitors
EP2935248B1 (en) 2012-12-21 2018-02-28 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
US9233974B2 (en) 2012-12-21 2016-01-12 Gilead Sciences, Inc. Antiviral compounds
AU2014214846A1 (en) 2013-02-08 2015-07-23 Celgene Avilomics Research, Inc. ERK inhibitors and uses thereof
PT2964229T (pt) 2013-03-06 2020-03-23 Janssen Pharmaceutica Nv Moduladores de piridina benzimidazol-2-ilo do recetor h4 de histamina
NO335177B1 (no) 2013-03-06 2014-10-13 Cambi Technology As Fremgangsmåte og anordning for termisk biologisk nedbryting og avvanning av biomasse
SG11201507255QA (en) 2013-03-14 2015-10-29 Newlink Genetics Corp Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization
PE20151727A1 (es) 2013-03-14 2015-12-17 Boehringer Ingelheim Int Acido 2-aza-biciclo[2.2.1]heptano-3-carboxilico (bencil-ciano-metil)-amidas sustituidas inhibidores de catepsina c
NZ710765A (en) 2013-03-14 2020-05-29 Glaxosmithkline Ip No 2 Ltd 2,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
CN105209449B (zh) 2013-03-14 2019-02-01 库拉德夫制药私人有限公司 犬尿氨酸途径的抑制剂
WO2014152537A1 (en) 2013-03-14 2014-09-25 Janssen Pharmaceutica Nv P2x7 modulators
ES2654288T3 (es) 2013-03-14 2018-02-13 Janssen Pharmaceutica, N.V. Moduladores de P2X7
TWI627174B (zh) 2013-03-14 2018-06-21 比利時商健生藥品公司 P2x7調控劑
JO3383B1 (ar) 2013-03-14 2019-03-13 Lilly Co Eli مثبطات cdc7
US9242969B2 (en) 2013-03-14 2016-01-26 Novartis Ag Biaryl amide compounds as kinase inhibitors
TWI644671B (zh) 2013-03-14 2018-12-21 比利時商健生藥品公司 P2x7調節劑
JP6275242B2 (ja) 2013-03-29 2018-02-07 オゲダ エス.エー. 選択的NK−3受容体拮抗薬としての新規なN−アシル−(3位置換)−(8−メチル)−5,6−ジヒドロ−[1,2,4]トリアゾロ[4,3−a]ピラジン、その医薬組成物、NK−3受容体媒介性障害で使用する方法
US20150057260A1 (en) 2013-08-22 2015-02-26 Genentech, Inc. Alkynyl alcohols and methods of use
US9611252B2 (en) 2013-12-30 2017-04-04 Lifesci Pharmaceuticals, Inc. Therapeutic inhibitory compounds
AU2015314851B2 (en) 2014-09-11 2020-01-02 Janssen Pharmaceutica Nv Substituted 2-azabicycles and their use as orexin receptor modulators
CA2960968A1 (en) 2014-09-12 2016-03-17 Janssen Pharmaceutica Nv P2x7 modulators
WO2016039983A1 (en) 2014-09-12 2016-03-17 Janssen Pharmaceutica Nv P2x7 modulating n-acyl-triazolopyrazines
RU2742305C2 (ru) 2014-12-30 2021-02-04 Новира Терапьютикс, Инк. Производные и способы лечения инфекций гепатита в
US10106556B2 (en) 2015-03-30 2018-10-23 Takeda Pharmaceutical Company Limited Heterocyclic compound
TN2017000544A1 (en) 2015-07-31 2019-04-12 Pfizer 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as magl inhibitors
WO2017087858A1 (en) 2015-11-20 2017-05-26 Abide Therapeutics, Inc. Pyrazole compounds and methods of making and using same
CN108017636A (zh) 2016-11-04 2018-05-11 合帕吉恩治疗公司 作为fxr调节剂的含氮杂环化合物
US10934276B2 (en) 2016-12-16 2021-03-02 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor M4
CN110198944A (zh) 2017-01-23 2019-09-03 辉瑞大药厂 作为单酰基甘油脂肪酶抑制剂的杂环螺环化合物
WO2020065614A1 (en) 2018-09-28 2020-04-02 Janssen Pharmaceutica Nv Monoacylglycerol lipase modulators
EP3856178B1 (en) 2018-09-28 2026-03-11 Janssen Pharmaceutica NV Monoacylglycerol lipase modulators
WO2020211798A1 (zh) 2019-04-16 2020-10-22 上海翰森生物医药科技有限公司 含二并环类衍生物抑制剂、其制备方法和应用
MX2022003819A (es) 2019-09-30 2022-05-11 Janssen Pharmaceutica Nv Ligandos de pet de mgl radiomarcados.
BR112022019077A2 (pt) 2020-03-26 2022-12-27 Janssen Pharmaceutica Nv Moduladores da monoacilglicerol lipase

Similar Documents

Publication Publication Date Title
JP2022502424A5 (https=)
AU2019240299B2 (en) SHP2 phosphatase inhibitors and methods of use thereof
JP7482116B2 (ja) モノアシルグリセロールリパーゼ調節因子
RU2018112230A (ru) Бициклические соединения в качестве ингибиторов atx
JP2021503004A5 (https=)
WO2025049746A1 (en) Compositions comprising werner syndrome helicase inhibitors and methods of using the same
KR101862327B1 (ko) 피리돈 및 아자-피리돈 화합물 및 사용 방법
CN114728935A (zh) Shp2抑制剂
JP2016504363A5 (https=)
JP2015504057A5 (https=)
RU2015131148A (ru) СОЕДИНЕНИЯ, ГЕТЕРОБИЦИКЛО-ЗАМЕЩЕННЫЕ-[1, 2, 4]ТРИАЗОЛО[1, 5c]ХИНАЗОЛИН-5-АМИНА, ОБЛАДАЮЩИЕ СВОЙСТВАМИ А2А АНТАГОНИСТОВ
HRP20120105T1 (hr) Aminoheterociklički spojevi
KR20140059195A (ko) 트리시클릭 헤테로시클릭 화합물 및 jak 저해제
WO2015171527A1 (en) Pyrazolopyridine pyrazolopyrimidine and related compounds
KR20150002573A (ko) 벤조티아졸-6-일 아세트산 유도체 및 hiv 감염을 치료하기 위한 이의 용도
JP2014528482A5 (https=)
JP2023548657A (ja) がんの処置に使用するための、egfrおよび/またはher2のヘテロ環阻害剤
US20240109900A1 (en) Azabicyclic shp2 inhibitors
JPWO2020065613A5 (https=)
KR20230079003A (ko) 안드로겐 수용체 조절제로서의 인돌 화합물
JPWO2020252353A5 (https=)
KR20230107291A (ko) PPARγ 조절제 및 사용 방법
JPWO2020065614A5 (https=)
CA3250387A1 (en) Tetrahydropyrido[3,4-D]pyrimidine compounds used as HPK1 inhibitors
RU2021111918A (ru) Модуляторы моноацилглицерин-липазы